Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing
- PMID: 30291498
- DOI: 10.1007/s10911-018-9417-z
Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing
Abstract
Recent advances in genome-wide sequencing technologies have provided researchers with unprecedented opportunities to discover the genomic structures of gene regulatory units in living organisms. In particular, the integration of ChIP-seq, RNA-seq, and DNase-seq techniques has facilitated the mapping of a new class of regulatory elements. These elements, called super-enhancers, can regulate cell-type-specific gene sets and even fine-tune gene expression regulation in response to external stimuli, and have become a hot topic in genome biology. However, there is scant genetic evidence demonstrating their unique biological relevance and the mechanisms underlying these biological functions. In this review, we describe a robust genome-wide strategy for mapping cell-type-specific enhancers or super-enhancers in the mammary genome. In this strategy, genome-wide screening of active enhancer clusters that are co-occupied by mammary-enriched transcription factors, co-factors, and active enhancer marks is used to identify bona fide mammary tissue-specific super-enhancers. The in vivo function of these super-enhancers and their associated regulatory elements may then be investigated in various ways using the advanced CRISPR/Cas9 genome-editing technology. Based on our experience targeting various mammary genomic sites using CRISPR/Cas9 in mice, we comprehensively discuss the molecular consequences of the different targeting methods, such as the number of gRNAs and the dependence on their simultaneous or sequential injections. We also mention the considerations that are essential for obtaining accurate results and shed light on recent progress that has been made in developing modified CRISPR/Cas9 genome-editing techniques. In the future, the coupling of advanced genome-wide sequencing and genome-editing technologies could provide new insights into the complex genetic regulatory networks involved in mammary-gland development.
Keywords: CRISPR/Cas9; Cell type-specific gene regulation; Genome-wide analysis; Mammary gland development; Super-enhancer.
Similar articles
-
STAT5-Driven Enhancers Tightly Control Temporal Expression of Mammary-Specific Genes.J Mammary Gland Biol Neoplasia. 2019 Mar;24(1):61-71. doi: 10.1007/s10911-018-9418-y. Epub 2018 Oct 17. J Mammary Gland Biol Neoplasia. 2019. PMID: 30328555 Review.
-
Identifying Novel Enhancer Elements with CRISPR-Based Screens.ACS Chem Biol. 2018 Feb 16;13(2):326-332. doi: 10.1021/acschembio.7b00778. Epub 2018 Jan 10. ACS Chem Biol. 2018. PMID: 29300083 Free PMC article. Review.
-
Mammary-Enriched Transcription Factors Synergize to Activate the Wap Super-Enhancer for Mammary Gland Development.Int J Mol Sci. 2022 Oct 2;23(19):11680. doi: 10.3390/ijms231911680. Int J Mol Sci. 2022. PMID: 36232979 Free PMC article.
-
Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing.Nat Commun. 2020 Jan 24;11(1):485. doi: 10.1038/s41467-020-14362-5. Nat Commun. 2020. PMID: 31980609 Free PMC article.
-
An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome.Neuropeptides. 2017 Aug;64:101-107. doi: 10.1016/j.npep.2016.11.003. Epub 2016 Nov 4. Neuropeptides. 2017. PMID: 27866656 Free PMC article.
Cited by
-
Super-enhancer omics in stem cell.Mol Cancer. 2024 Aug 1;23(1):153. doi: 10.1186/s12943-024-02066-z. Mol Cancer. 2024. PMID: 39090713 Free PMC article. Review.
-
The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.Int J Biol Sci. 2023 Jan 22;19(4):1036-1048. doi: 10.7150/ijbs.78535. eCollection 2023. Int J Biol Sci. 2023. PMID: 36923930 Free PMC article. Review.
-
Analysis of super-enhancer using machine learning and its application to medical biology.Brief Bioinform. 2023 May 19;24(3):bbad107. doi: 10.1093/bib/bbad107. Brief Bioinform. 2023. PMID: 36960780 Free PMC article. Review.
-
CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research.Front Med (Lausanne). 2021 Mar 3;8:649896. doi: 10.3389/fmed.2021.649896. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33748164 Free PMC article. Review.
-
Oncogenic seRNA functional activation: a novel mechanism of tumorigenesis.Mol Cancer. 2020 Apr 11;19(1):74. doi: 10.1186/s12943-020-01195-5. Mol Cancer. 2020. PMID: 32278350 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources